- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 159
Despegar draws up $100m IPO plans
Latin American travel booking platform Despegar has filed to go public in the US, two years after Expedia invested $270m for a 16% share in the company.
Aug 17, 2017Youon docks at $87m IPO
Youon has become the first bike sharing company to complete an initial public offering in China, providing an exit to Alibaba's Ant Financial affiliate.
Aug 17, 2017MongoDB makes confidential IPO move
The Salesforce, Intel and Red Hat-backed database software provider, valued at $1.6bn as of 2016, has reportedly filed for an initial public offering.
Aug 16, 2017Wantedly wanders toward public markets
The CyberAgent and Nihon Keizai Shimbun-backed recruitment and networking platform developer is set to float in its home country of Japan next month.
Aug 14, 2017Iheima hits public markets
Iheima has raised $27.3m in its initial public offering, becoming the first incubator to float in China and providing an exit to corporate investors Toread and Youyou.
Aug 10, 2017Clementia cleaves $120m from IPO
UCB Pharma scored an exit after the bone disease therapy developer floated at the top of its range, having secured $92.5m in funding over the past two years.
Aug 3, 2017Roku to greenlight IPO
Roku, which first considered a flotation almost three years ago, is said to have hired underwriters for an initial public offering that could value it at up to $1bn.
Jul 14, 2017Sienna to scratch IPO itch
Topical skin treatment developer and JLabs graduate Sienna Biopharmaceuticals has filed for a $74.8m initial public offering, after raising $86m in venture funding.
Jul 7, 2017MyRepublic begins journey to IPO
Sinar Mas and Dian Swastatika Sentosa-backed internet service provider MyRepublic is targeting the end of 2018 for an initial public offering, its CEO has said.
Jul 6, 2017Clementia to form $115m IPO
The bone disease therapy developer had raised $92.5m from investors including UCB Pharma across two rounds in 2015.
Jul 4, 2017About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


